Why I Can't Stop Buying Nvidia Stock

NVIDIA delivered accelerating growth across FY2026, with revenue up 65.47% to $215.93B, net income up 64.75% to $120.06B, and Q4 revenue rising 73.21% year over year to $68.12B. Q1 FY2027 revenue guidance of about $78.0B remains strong despite excluding China Data Center compute revenue, while free cash flow reached $96.57B for the year and the company returned $41.1B to shareholders. The article argues the AI moat is deepening via Blackwell and Vera Rubin adoption, even as export restrictions remain a risk.

Analysis

This is less a one-name earnings story than a capex super-cycle rerating of the entire AI supply chain. NVDA remains the clearest economic toll collector, but the second-order winner is the infrastructure layer: networking, optical interconnect, and systems integrators with exposure to hyperscaler AI buildouts should see demand duration extend well beyond the current GPU upgrade cycle. The biggest implication is that competition is shifting from chip-level performance to platform-level switching costs; that is structurally bullish for vendors embedded in deployment standards and deployment services, and bearish for any incremental share gain attempt by smaller accelerator players.

The market is likely underestimating how much of the current growth is coming from pre-commitment rather than spot demand. When customers are booking capacity years ahead, the relevant risk is not near-term unit demand but digestion risk in 2-4 quarters if deployments slip or inference efficiency improves faster than workloads expand. That said, the more immediate catalyst path is still intact: every new platform launch, hyperscaler deployment update, and backlog revision can force another estimate reset, which keeps momentum buyers engaged and short interest structurally uncomfortable.

The contrarian read is that valuation is only cheap if the growth rate remains extraordinarily high for longer than consensus expects. The stock can still work from here, but the setup is increasingly sensitive to any guide-down in backlog conversion, China leakage beyond guidance, or signs that customers are pausing to digest prior shipments. The bigger medium-term threat is not competition; it is elasticity—if software optimization or model efficiency reduces incremental accelerator demand, the multiple compresses before revenue growth visibly rolls over.

Key Decisions for Investors

• Stay long NVDA, but prefer call spreads over outright equity into the next earnings window: buy 3-6 month call spreads 10-15% out-of-the-money to capture estimate-revision momentum while limiting downside if guidance normalizes.
• Add to MSFT and AMZN only on weakness as secondary beneficiaries of AI infrastructure spend; use them as lower-beta expressions of the same capex cycle with better downside protection than NVDA if the trade gets crowded.
• Initiate a basket long in AI infrastructure adjacencies against a short in any non-NVDA AI accelerator proxy that trades on future share-taking narratives; the thesis is that platform lock-in, not silicon specs, will dominate ordering behavior over the next 2-4 quarters.
• Take profits incrementally on NVDA after large post-print gaps: trim 20-30% on moves that imply forward multiple expansion rather than earnings revision, and recycle into pullbacks where the market reverts to FCF support.
• Watch for any sign of hyperscaler capex digestion over the next two quarters; if order cadence slows, rotate from NVDA beta into cash-generative software/infra names before the market prices in a growth deceleration.